Doe CP - Search Results

1

Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.

Heath BM, Cui Y, Worton S, Lawton B, Ward G, Ballini E, Doe CP, Ellis C, Patel BA, McMahon NC. Heath BM, et al. Among authors: doe cp. J Pharmacol Toxicol Methods. 2011 May-Jun;63(3):258-68. doi: 10.1016/j.vascn.2010.12.004. Epub 2010 Dec 29. J Pharmacol Toxicol Methods. 2011. PMID: 21194571

2

A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.

Batey AJ, Doe CP. Batey AJ, et al. Among authors: doe cp. J Pharmacol Toxicol Methods. 2002 Jul-Aug;48(1):11-9. doi: 10.1016/S1056-8719(03)00009-1. J Pharmacol Toxicol Methods. 2002. PMID: 12750037

3

Tachycardia-induced primate model of heart failure in cardiovascular drug discovery.

Smith AH, Wolfgang EA, Flynn DM, Doe CP, Knight DR. Smith AH, et al. Among authors: doe cp. J Pharmacol Toxicol Methods. 2000 Mar-Apr;43(2):125-31. doi: 10.1016/s1056-8719(00)00099-x. J Pharmacol Toxicol Methods. 2000. PMID: 11150740

4

Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.

Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, Turner GH, Ju H, Thomas H, Fishman CE, Sulpizio A, Behm DJ, Hoffman S, Lin Z, Lozinskaya I, Casillas LN, Lin M, Trout RE, Votta BJ, Thorneloe K, Lashinger ES, Figueroa DJ, Marquis R, Xu X. Willette RN, et al. Among authors: doe cp. J Pharmacol Exp Ther. 2008 Aug;326(2):443-52. doi: 10.1124/jpet.107.134551. Epub 2008 May 22. J Pharmacol Exp Ther. 2008. PMID: 18499744

5

NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine.

Forfia PR, Zhang X, Knight DR, Smith AH, Doe CP, Wolfgang EA, Flynn DM, Wolin MS, Hintze TH. Forfia PR, et al. Among authors: doe cp. Am J Physiol. 1999 Jun;276(6):H2069-75. doi: 10.1152/ajpheart.1999.276.6.H2069. Am J Physiol. 1999. PMID: 10362689

6

Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.

Willette RN, Eybye ME, Olzinski AR, Behm DJ, Aiyar N, Maniscalco K, Bentley RG, Coatney RW, Zhao S, Westfall TD, Doe CP. Willette RN, et al. Among authors: doe cp. J Pharmacol Exp Ther. 2009 Sep;330(3):964-70. doi: 10.1124/jpet.109.154443. Epub 2009 Jun 25. J Pharmacol Exp Ther. 2009. PMID: 19556450

7

Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.

Doe C, Bentley R, Behm DJ, Lafferty R, Stavenger R, Jung D, Bamford M, Panchal T, Grygielko E, Wright LL, Smith GK, Chen Z, Webb C, Khandekar S, Yi T, Kirkpatrick R, Dul E, Jolivette L, Marino JP Jr, Willette R, Lee D, Hu E. Doe C, et al. J Pharmacol Exp Ther. 2007 Jan;320(1):89-98. doi: 10.1124/jpet.106.110635. Epub 2006 Oct 3. J Pharmacol Exp Ther. 2007. PMID: 17018693

8

Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.

Behm DJ, Harrison SM, Ao Z, Maniscalco K, Pickering SJ, Grau EV, Woods TN, Coatney RW, Doe CP, Willette RN, Johns DG, Douglas SA. Behm DJ, et al. Among authors: doe cp. Br J Pharmacol. 2003 May;139(2):464-72. doi: 10.1038/sj.bjp.0705254. Br J Pharmacol. 2003. PMID: 12770952 Free PMC article.

9

Urotensin-II: a novel systemic hypertensive factor in the cat.

Behm DJ, Doe CP, Johns DG, Maniscalco K, Stankus GP, Wibberley A, Willette RN, Douglas SA. Behm DJ, et al. Among authors: doe cp. Naunyn Schmiedebergs Arch Pharmacol. 2004 Mar;369(3):274-80. doi: 10.1007/s00210-004-0873-1. Epub 2004 Feb 19. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14985938

10

The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.

Behm DJ, Stankus G, Doe CP, Willette RN, Sarau HM, Foley JJ, Schmidt DB, Nuthulaganti P, Fornwald JA, Ames RS, Lambert DG, Calo' G, Camarda V, Aiyar NV, Douglas SA. Behm DJ, et al. Among authors: doe cp. Br J Pharmacol. 2006 May;148(2):173-90. doi: 10.1038/sj.bjp.0706716. Br J Pharmacol. 2006. PMID: 16547525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page